Integrated Diagnostics Pink Sheet Forecast - Naive Prediction
| IDGXF Stock | USD 0.68 0.00 0.00% |
The Naive Prediction forecasted value of Integrated Diagnostics Holdings on the next trading day is expected to be 0.67 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.76. Integrated Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Integrated Diagnostics' historical fundamentals, such as revenue growth or operating cash flow patterns.
The relative strength index (RSI) of Integrated Diagnostics' share price is above 70 as of 22nd of January 2026. This usually indicates that the pink sheet is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Integrated, making its price go up or down. Momentum 73
Buy Stretched
Oversold | Overbought |
Using Integrated Diagnostics hype-based prediction, you can estimate the value of Integrated Diagnostics Holdings from the perspective of Integrated Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Integrated Diagnostics Holdings on the next trading day is expected to be 0.67 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.76. Integrated Diagnostics after-hype prediction price | USD 0.68 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Integrated |
Integrated Diagnostics Additional Predictive Modules
Most predictive techniques to examine Integrated price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Integrated using various technical indicators. When you analyze Integrated charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Integrated Diagnostics Naive Prediction Price Forecast For the 23rd of January
Given 90 days horizon, the Naive Prediction forecasted value of Integrated Diagnostics Holdings on the next trading day is expected to be 0.67 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0004, and the sum of the absolute errors of 0.76.Please note that although there have been many attempts to predict Integrated Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Integrated Diagnostics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Integrated Diagnostics Pink Sheet Forecast Pattern
| Backtest Integrated Diagnostics | Integrated Diagnostics Price Prediction | Buy or Sell Advice |
Integrated Diagnostics Forecasted Value
In the context of forecasting Integrated Diagnostics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Integrated Diagnostics' downside and upside margins for the forecasting period are 0.01 and 4.47, respectively. We have considered Integrated Diagnostics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Integrated Diagnostics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Integrated Diagnostics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.3665 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0125 |
| MAPE | Mean absolute percentage error | 0.0207 |
| SAE | Sum of the absolute errors | 0.76 |
Predictive Modules for Integrated Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Integrated Diagnostics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Integrated Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Integrated Diagnostics After-Hype Price Prediction Density Analysis
As far as predicting the price of Integrated Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Integrated Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Integrated Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Integrated Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting Integrated Diagnostics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Integrated Diagnostics' historical news coverage. Integrated Diagnostics' after-hype downside and upside margins for the prediction period are 0.03 and 4.48, respectively. We have considered Integrated Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Integrated Diagnostics is abnormally volatile at this time. Analysis and calculation of next after-hype price of Integrated Diagnostics is based on 3 months time horizon.
Integrated Diagnostics Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Integrated Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Integrated Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Integrated Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.46 | 3.80 | 0.00 | 4.15 | 0 Events / Month | 9 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.68 | 0.68 | 0.00 |
|
Integrated Diagnostics Hype Timeline
Integrated Diagnostics is currently traded for 0.68. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -4.15. Integrated is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.46%. %. The volatility of related hype on Integrated Diagnostics is about 42.11%, with the expected price after the next announcement by competition of -3.47. About 27.0% of the company shares are held by company insiders. The company last dividend was issued on the 8th of July 2021. Integrated Diagnostics had 4:1 split on the 24th of December 2020. Assuming the 90 days horizon the next anticipated press release will be uncertain. Check out Historical Fundamental Analysis of Integrated Diagnostics to cross-verify your projections.Integrated Diagnostics Related Hype Analysis
Having access to credible news sources related to Integrated Diagnostics' direct competition is more important than ever and may enhance your ability to predict Integrated Diagnostics' future price movements. Getting to know how Integrated Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Integrated Diagnostics may potentially react to the hype associated with one of its peers.
Other Forecasting Options for Integrated Diagnostics
For every potential investor in Integrated, whether a beginner or expert, Integrated Diagnostics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Integrated Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Integrated. Basic forecasting techniques help filter out the noise by identifying Integrated Diagnostics' price trends.View Integrated Diagnostics Related Equities
| Risk & Return | Correlation |
Integrated Diagnostics Market Strength Events
Market strength indicators help investors to evaluate how Integrated Diagnostics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Integrated Diagnostics shares will generate the highest return on investment. By undertsting and applying Integrated Diagnostics pink sheet market strength indicators, traders can identify Integrated Diagnostics Holdings entry and exit signals to maximize returns.
Integrated Diagnostics Risk Indicators
The analysis of Integrated Diagnostics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Integrated Diagnostics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting integrated pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.2 | |||
| Standard Deviation | 3.8 | |||
| Variance | 14.45 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Integrated Diagnostics
The number of cover stories for Integrated Diagnostics depends on current market conditions and Integrated Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Integrated Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Integrated Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Integrated Pink Sheet
Integrated Diagnostics financial ratios help investors to determine whether Integrated Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Integrated with respect to the benefits of owning Integrated Diagnostics security.